The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Sodium-ion batteries show promise as a cheaper, more sustainable alternative to lithium-ion but need major advancements to become competitive. Stanford’s STEER study emphasizes that innovation, not ...

One of the most promising Gen-IV designs is the sodium-cooled fast reactor (SFR). “SFRs with metallic-alloy fuel are garnering a significant amount of interest because they have intrinsic ...